Skip to main content

and
  1. No Access

    Article

    The Role of Vandetanib in the Second-Line Treatment for Advanced Non-Small-Cell-Lung Cancer: A Meta-Analysis of Four Randomized Controlled Trials

    The purpose of this study was to assess the efficacy and toxicity of vandetanib in the second-line treatment for advanced non-small cell lung cancer (NSCLC).

    Wei-**ang Qi, Li-Na Tang, Ai-Na He, Zan Shen, Yang Yao in Lung (2011)

  2. No Access

    Article

    Doublet Versus Single Cytotoxic Agent as First-Line Treatment for Elderly Patients with Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

    The aim of this study was to perform a systematic review and meta-analysis of all randomized controlled trials that compared the efficacy of doublet versus single third-generation cytotoxic agent as first-line...

    Wei-**ang Qi, Li-na Tang, Ai-na He, Zan Shen, Feng Lin, Yang Yao in Lung (2012)